Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces by Italia A Asteriti et al.
RESEARCH Open Access
Aurora-A inactivation causes mitotic spindle pole
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generated forces
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Abstract
Background: Aurora-A is an oncogenic kinase playing well-documented roles in mitotic spindle organisation. We
previously found that Aurora-A inactivation yields the formation of spindles with fragmented poles that can drive
chromosome mis-segregation. Here we have addressed the mechanism through which Aurora-A activity regulates
the structure and cohesion of spindle poles.
Results: We inactivated Aurora-A in human U2OS osteosarcoma cells either by RNA-interference-mediated
silencing or treating cultures with the specific inhibitor MLN8237. We show that mitotic spindle pole fragmentation
induced by Aurora-A inactivation is associated with microtubule hyperstabilisation. Silencing of the microtubule-
stabilising factor ch-TOG prevents spindle pole fragmentation caused by inactivation of Aurora-A alone and
concomitantly reduces the hyperstabilisation of microtubules. Furthermore, decreasing pole-directed spindle forces
by inhibition of the Eg5 kinesin, or by destabilisation of microtubule-kinetochore attachments, also prevents pole
fragmentation in Aurora-A-inactivated mitoses.
Conclusions: Our findings indicate that microtubule-generated forces are imbalanced in Aurora-A-defective cells
and exert abnormal pressure at the level of spindle poles, ultimately causing their fragmentation. This study
therefore highlights a novel role of the Aurora-A kinase in regulating the balance between microtubule forces
during bipolar spindle assembly.
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Background
The assembly of a bipolar mitotic spindle is a highly
dynamic process essential for balanced chromosome
segregation in mitosis. Defects in the spindle bipolar
architecture can cause unequal chromosome segregation
to daughter cells and represent a source of aneuploidy
and genetic instability in cancer cells. Microtubule
(MT)-generated forces drive the dynamic movements of
centrosomes, chromosomes and MTs themselves and
are essential players in the build-up of the mitotic bipo-
lar spindle (see [1-3] for reviews). These forces are gen-
erated by the directional movement of motor proteins
along MTs (reviewed in [4]) and depend on the dynamic
properties of MTs [3]. The establishment of a proper
spindle geometry and bipolar organisation requires a
regulated balance between opposite directional forces
exerted along growing MTs [5,6]. Given that improperly
assembled or multipolar spindles can drive chromosome
mis-segregation, there is a growing research focus on
the mechanisms through which this balance is
generated.
Phosphorylation-based signalling networks play key
roles in orchestrating the concerted action of mitotic
MT regulators. The mitotic kinase Aurora-A localises at
centrosomes and along the mitotic spindle MTs; therein,
it phosphorylates a variety of factors required for entry
into mitosis, maturation and separation of centrosomes
and mitotic spindle organisation (reviewed in [7,8]).
Aurora-A is encoded by a cancer-associated gene that is
amplified and/or overexpressed in several tumor types
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([9,10], see [11,12] for recent reviews). Increased Aur-
ora-A protein abundance can also be determined at the
post-transcriptional level through various mechanisms,
including the interaction with stabilising factors
([13-15]; see [16] for a review). Aurora-A overexpression
can induce aneuploidy through various routes in differ-
ent cellular contexts, including centrosome amplification
([17]; reviewed in [18]), faulty cell division [19] or wea-
kened mitotic checkpoint activity [20]. Aurora-A is
therefore intrinsically oncogenic and it is regarded as a
potential target in anti-cancer therapy (reviewed in
[11,21]). Novel molecules with Aurora-A-inhibitory
activity are being designed in many laboratories, some
of which have yielded promising results in pre-clinical
studies and are under evaluation in phase I and II clini-
cal trials (see [12] for a recent review). These observa-
tions highlight the importance of unraveling Aurora-A
downstream processes. Furthermore, they call for
increasing attention on elucidating potentially adverse
consequences of Aurora-A inactivation on cell division.
We previously noticed that RNA interference (RNAi)-
mediated inactivation of Aurora-A in human cells yields
the formation of multipolar spindles, that originate from
MT-dependent fragmentation of the pericentriolar
material (PCM) and are not associated with centrosome
amplification [22,23]. Multipolar spindles also form in
cells injected with anti-Aurora-A antibodies [24] or trea-
ted with the Aurora-A specific inhibitor MLN8054 [25].
These lines of evidence indicate that Aurora-A is
required for maintenance of spindle pole integrity. An
analysis of spindles with fragmented poles in Aurora-A-
silenced (thereafter indicated as Aurora-Ai) cells
revealed that there was an altered localisation of the
MT regulators ch-TOG (colonic and hepatic tumor
over-expressed gene) and MCAK (mitotic centromere-
associated kinesin) at spindle poles [23]. MCAK is a
MT-depolymerising kinesin [26], whereas ch-TOG is a
MT-stabilising factor with MT-polymerising activity
(reviewed in [27]) that regulates the overall MT
dynamics in human cells [28,29]. MCAK and ch-TOG
antagonistic functions need be accurately balanced to
ensure proper spindle pole organisation [30]. We pre-
viously reported that RNAi-mediated inactivation of
Aurora-A yielded an abnormal accumulation of ch-TOG
at spindle poles. Furthermore, the concomitant inactiva-
tion of ch-TOG restored spindle pole cohesion in Aur-
ora-Ai cells [23]. These findings and the observation
that PCM fragmentation is MT-dependent [23], suggest
that effects of Aurora-A inactivation on the spindle pole
structure implicate an altered MT dynamics. However,
the functional connection between Aurora-A, the activ-
ity of MT-regulatory factors and the structural organisa-
tion of spindle poles remains to be yet clarified
mechanistically.
Here we have investigated the dynamic properties of
MTs in Aurora-A-defective mitoses and show that they
are hyperstable, a feature that is reversed by concomi-
tant inactivation of ch-TOG. We then devised several
unrelated strategies to decrease pole-directed spindle
MT forces in cells in which Aurora-A was inactivated
by either RNAi-mediated silencing or by the specific
inhibitor MLN8237. We report that these independent
approaches converge in preventing spindle pole disrup-
tion in Aurora-A-defective mitoses. These results there-
fore highlight a novel role of Aurora-A in modulating
spindle MT-associated forces directed towards centro-
somes, which ultimately regulate spindle pole cohesion.
This newly emerging role places Aurora-A upstream of
a novel mechanism that regulates the balanced segrega-
tion of chromosomes along a bipolar spindle axis.
Methods
Cell cultures, synchronisation protocols and treatments
U2OS cells (ATCC: HTB-96) were cultured as described
[23]. For synchronisation, cells were subjected to a 24
hours block in 2 mM thymidine. Cultures were then
released from the G1/S arrest by washing away the thy-
midine and adding fresh medium containing 30 μM
deoxycytidine; about 10 hours post-release (see Figures)
mitoses-enriched cultures were fixed and processed for
immunofluorescence (IF) as described below. MLN8237
(20 or 50 nM, as indicated; Selleck Chemicals, Houston,
TX, USA) and monastrol (MON, 100 μM; Biomol Inter-
national, PA, USA) were added to thymidine-released
cultures at the indicated times before harvesting. When
indicated, asynchronously growing cultures were treated
with MON for 6 hours; cultures were then washed three
times in warm medium and released in complete med-
ium for 30 and 60 minutes. For MT depolymerisation
experiments, cells were incubated on ice for 10, 15 and
20 minutes, then fixed and processed for IF.
RNAi
cDNA sequences targeted by small interfering (si)RNA
oligonucleotides (QIAGEN, Hilden, Germany or Applied
Biosystems/Ambion, Austin, TX, USA) are: 725-
ATGCCCTGTCTTACTGTCA-743 (Aurora-A), 126-
GAGCCCAGAGTGGTCCAAA-144 (ch-TOG), 397-
GCATGCCGTGAAACGTATA-415 (Nuf2, kindly pro-
vided by P. Meraldi; described in [31]). A GL2 siRNA
duplex targeting the luciferase gene was used for con-
trol. Final concentrations of siRNA oligonucleotides
were: 80 nM (Aurora-A and GL2), 40 nM (ch-TOG)
and 60 nM (Nuf2). In cotransfections of Aurora-A and
either ch-TOG or Nuf2 siRNAs the final amount of
siRNA oligonucleotides in control cultures was balanced
(to 120 or 140 nM, respectively) by adding GL2 oligo.
Transfection reagent was Oligofectamine (Invitrogen,
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Carslbad, CA, USA). When experiments were carried
out in synchronous cultures, siRNAs were transfected at
the moment of thymidine treatment. Cultures were ana-
lysed 48 hours after transfection (asynchronous cultures)
or at the indicated times after thymidine release (syn-
chronised cultures). Experiments were repeated 2 to 4
times; statistical analysis of data was performed using
the c2 test and calculating standard deviations (s.d.), as
indicated.
IF
Cells grown on coverslips were fixed as follows: (a) -20°
C methanol, 6 minutes; or (b) 4% PFA plus TritonX-100
0.2% in Pipes pH 6.9 20 mM, MgCl2 1 mM, EGTA 10
mM, 10 minutes at room temperature. Blocking and all
antibody incubations were performed at room tempera-
ture in PBS/0.05% Tween 20/3% BSA. Cells were coun-
terstained with 4,6-diamidino-2-phenylindole (DAPI,
0.05 μg/ml) and mounted using Vectashield (Vector
Laboratories, Burlingame, CA, USA). Primary antibodies
were: anti-alpha-tubulin (1:2 000, B-5-1-2, Sigma, St
Louis, MO, USA), anti-Aurora-A (0.5 μg/ml, BD Trans-
duction Laboratories, Franklin Lakes, NJ, USA), anti-
phospho-Aurora-A (Thr288) (C39D8; Cell Signaling
Technology, Danvers, MA, USA), anti-pericentrin (2 μg/
ml, ab4448; Abcam, Cambridge, UK), anti-ch-TOG
(1:25, ab18320, Abcam), anti-Nuf2 (1:300, kind gift of V.
Draviam, described in [31], or 5 μg/ml, ab17058,
Abcam). Samples were analysed using a Nikon (Tokyo,
Japan) Eclipse 90i microscope equipped with a Qicam
Fast 1394 CCD camera (Qimaging, Surrey, BC, Canada).
Image acquisition and deconvolution on 0.6-μm Z-serial
optical sections were performed using NIS-Elements AR
3.2 (Nikon); images were processed with Adobe Photo-
shop CS 8.0 and NIS-Elements AR 3.2.
Western immunoblotting (WB)
Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 8.0,
150 mM NaCl, 1% NP40, 1 mM EGTA, 0.25% sodium
deoxycholate) supplemented with protease and phospha-
tase inhibitors. Proteins were resolved by electrophoresis
on 10% Laemmli gel and transferred on a nitrocellulose
membrane (Protran BA83, Whatman, Kent, UK) using a
semi-dry system (BIO-RAD, Hercules, CA, USA). 30 μg
of extract per lane were loaded. Blocking and antibody
incubations were performed at room temperature in
PBS/0.1% Tween 20/5% low fat milk. Antibodies were:
anti-Aurora-A (0.5 μg/ml), anti-Nuf2 (1:1 000, kind gift
of V. Draviam), anti-actin (0.5 μg/ml, I-19; SantaCruz
Biotechnology, Santa Cruz, CA, USA). Signals were
visualized by enhanced chemiluminescence detection
(ECL plus, GE Healthcare, Waukesha, WI, USA, and Pro-
tein Detection System, GeneSpin, Milan, Italy).
Results
Aurora-A inactivation yields hyperstabilisation of mitotic
spindle MTs
Aurora-A can be effectively silenced by RNAi in human
cells, providing a useful tool to unravel the biological
functions of this kinase [22-24,32]. In our assays, transi-
ent transfection of Aurora-A-specific siRNA oligonu-
cleotides (48 hours) in human U2OS osteosarcoma cell
cultures routinely reduced the overall Aurora-A protein
level by about 90% of that measured in control cultures
by WB assays. By single-cell IF analysis, Aurora-A sig-
nals were virtually undetectable or extremely reduced in
over 80% of Aurora-Ai mitotic cells [22,23]. A signifi-
cant fraction of these Aurora-Ai mitoses displayed spin-
dles with multiple poles (indicated thereafter as
“extrapoles”) [22,23], which were abolished by co-inacti-
vating the MT-stabilising factor ch-TOG in Aurora-Ai
cells. We therefore wondered whether the dynamic
properties of the spindle MTs are altered when Aurora-
A function is disrupted. MT-stabilising and MT-depoly-
merising factors influence the rate of MT growth and
shrinkage, which together determine the overall dynamic
instability of MTs. Assaying the sensitivity of MTs to
depolymerisation at low temperatures, in the presence
or absence of a specific protein, can be used to assess
the “protective” effect conferred by that factor, or
absence thereof. We first investigated the sensitivity of
MTs to ice-induced depolymerisation in a time-course
analysis in Aurora-Ai cultures. Control cultures were
interfered with neutral siRNAs, indicated as GL2i. After
48 hours of RNAi, cultures were incubated for 10, 15 or
20 minutes on ice and the status of MT polymerisation
was examined in prometaphase (PM) and metaphase
(M) cells (Figure 1A). In control GL2i cultures, mitotic
cells underwent gradual MT disassembly during cold
treatment: PM/M cells with polymerised MTs disap-
peared, paralleled by a gradual decrease over time of a
category defined as “partially depolymerised” spindles,
showing sparse, disorganised, yet still visible centro-
some-originating MTs; we found a corresponding
increase of the fully “depolymerised” category, in which
centrosomes were totally devoid of MTs and alpha-
tubulin was almost completely diffuse, with only stably
kinetochore (KT)-attached MTs (K-fibers) remaining
visible (exemplifying panels are shown in Figure 1A).
After 20 minutes on ice the fully depolymerised actually
became the almost exclusive or largely predominant
phenotype in GL2i controls (over 80% of all PM/M). In
Aurora-Ai PM/M, spindle MTs were significantly more
resistant and their depolymerisation kinetics was slower
compared to control cells (Figure 1A). Similar results
were obtained by separately comparing cells in either
the PM or the M stage, confirming a consistently slower
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cold-induced depolymerisation kinetics in Aurora-Ai
compared to GL2i samples in each stage (not shown):
thus, the increased resistance of MTs in Aurora-Ai cells
is not due to an increased number of K-fibers but,
rather, to an abnormal stability of non-KT MTs. Aur-
ora-Ai mitoses are delayed at the PM stage [22] and in
principle it was possible that the changes in MT
dynamics were a mere side-effect of the abnormally long
permanence of cells in this mitotic phase. We therefore
devised an independent approach to analyse MT
dynamics in Aurora-A-inactivated cells immediately
after entering the first mitotic division. To this aim we
pre-synchronised cultures at the G1/S transition, then
allowed cells to progress synchronously to mitosis; 1
hour before harvesting the cells, we treated cultures
with a recently developed specific Aurora-A inhibitor,
MLN8237 [33], a second generation ATP-competitive
molecule currently in phase I-II clinical trials [12].
Under these conditions Aurora-A is inactive, as shown
by the disappearance of Thr-288-phosphorylated, i.e.
active, Aurora-A (Figure 1B, IF panels and histograms).
We then performed the ice-induced depolymerisation
assay and fixed cells for IF analysis (see protocol in Fig-
ure 1B). We again observed a slower ice-induced MT
depolymerisation in Aurora-A-inactivated compared
with control cultures (Figure 1B): polymerised spindles
were still present in 10-20% of Aurora-A-defective PMs
after 15 and 20 minutes of ice-incubation while com-
plete MT depolymerisation was achieved with significant
slower kinetics compared with controls. This observa-
tion confirms that Aurora-A activity is required for nor-
mal MT dynamics at prometaphase.
The induction of spindle extrapoles in Aurora-Ai mitoses
is associated with ch-TOG-dependent MT
hyperstabilisation
We next assessed whether co-inactivation of ch-TOG,
which inhibits spindle pole fragmentation [23], also
modifies the properties of MTs in Aurora-Ai cells. We
used an RNAi protocol yielding efficient depletion of
both Aurora-A and ch-TOG proteins in U2OS cells
[23], then examined the status of MTs in double-inter-
fered (Aurora-Ai/ch-TOGi) compared with controls
(GL2i) and with single-interfered (either Aurora-Ai or
ch-TOGi) PM and M cells in ice-induced depolymerisa-
tion assays (15 minutes of incubation) (Figure 2A). ch-
TOGi PM/Ms showed effective ice-induced MT depoly-
merisation, with a somewhat higher frequency of the
fully depolymerised category compared to GL2i controls,
which is consistent with the loss of the MT-stabilising
function of ch-TOG in these cultures. Furthermore ch-
TOG co-inactivation in Aurora-A-defective cultures (ch-
TOGi/Aurora-Ai) reduced the MT hyperstabilisation
caused by Aurora-A inactivation alone and restored sen-
sitivity to ice-induced depolymerisation (Figure 2A). In
parallel, ch-TOG inactivation inhibited spindle pole
fragmentation in Aurora-Ai ice-incubated mitoses (Fig-
ure 2B). Therefore, Aurora-A silencing induces the
appearance of spindles with fragmented poles, abnormal
ch-TOG accumulation at poles [23] and hyperstabilisa-
tion of spindle MTs (Figure 1). Concomitant with this,
Figure 1 Aurora-A inactivation induces hyperstabilisation of
spindle MTs. A. PM and M cells from control (GL2) and Aurora-Ai
cultures incubated on ice for the indicated times were classified
according to the status of MTs, examplified in the IF panels. The
rightmost column indicates the number (n) of scored PM/M cells in
2 independent experiments; mean values (%) and s.d. (italics) are
indicated. B. The protocol of MLN8237 treatment in synchronous
cultures is shown (time intervals not represented to scale).
Histograms show the percentage of PM and M cells displaying active
pThr288-Aurora-A (p-Aur-A-positive) in control (DMSO) or MLN8237-
treated cultures (200 counted cells per condition, 2 experiments;
error bars represent s.d.); representative images are shown in the IF
panels. In the table below, DMSO- or MLN8237-treated cells
subjected to the ice-induced depolymerisation assay were classified
as in A (2 independent experiments). Scale bars: 10 μm.
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ch-TOG activity is itself required for both spindle pole
fragmentation ([23] and Figure 2B) and for increased
MT stability (Figure 2A) in Aurora-Ai mitoses.
If the disruption of mitotic spindle poles induced by
Aurora-A inactivation is not just concomitant with, but
is functionally linked to, the induction of hyperstable
MTs, then the “extrapole” phenotype in Aurora-Ai cul-
tures should be characteristically associated with spin-
dles composed of ice-resistant MTs. To test whether
this was the case, we examined how PM/M cells with
fragmented poles were represented within the MT cate-
gories described in Figure 1A after ice incubation. Pole
fragmentation was particularly represented (~16%,
representing a highly significant 5-fold induction
compared to controls) among Aurora-Ai PM/M with
ice-resistant MTs (Figure 2C). By contrast, no statisti-
cally significant occurrence of pole fragmentation was
detected among Aurora-Ai mitoses with partially or
fully depolymerised MTs compared with controls. ch-
TOGi/Aurora-Ai PM/M cells tended to have normal
bipolar spindles (see Figure 2B), and those rare cells
that displayed spindles with extrapoles showed no speci-
fic association with the MT status, being uniformly dis-
tributed among the different categories, similar to
multipolar mitoses occurring in control cultures (Figure
2C). We conclude that the absence of Aurora-A yields
spindle pole fragmentation in those mitoses in which
MTs are hyperstabilised.
Figure 2 Aurora-A and ch-TOG modulate the stability of spindle MTs in opposite manners. A. Cells interfered (i) with the indicated siRNAs
were incubated on ice for 15 minutes. Histograms represent the distribution of PM/M in the three MT categories identified in Figure 1A (at least
350 counted cells per condition, 2 experiments). B. PM/M with extrapoles were quantified (fold induction) in cultures interfered as indicated and
incubated for 15 minutes of ice (at least 600 counted cells per condition, 2 experiments). C. Histograms represent the distribution of mitoses
with fragmented spindle poles among the MT stability categories shown in Figure 1A (examples are shown in the IF panels). Around 700 PM/M
were counted for each interference (2 experiments). Error bars represent s.d. **: p < 0.001, c2 test. Scale bar: 10 μm.
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Eg5 is required for spindle pole fragmentation induced
by Aurora-A inactivation
The dynamic activity of MTs at poles is important to
counteract centrosome-directed MT forces that pull
spindle poles apart during spindle assembly in PM [1,4].
The evidence that spindle pole fragmentation in Aurora-
Ai mitoses only occurs in the presence of MTs [23], and
preferentially in PM/M cells harbouring hyperstable
MTs (Figure 2), suggests that in the absence of Aurora-
A spindle poles may be subjected to excessive MT-origi-
nating pressure that eventually causes them to fragment.
If that hypothesis is correct, inactivation of centrosome-
directed forces should inhibit spindle pole disruption in
Aurora-A-defective cells.
A prominent contribution to centrosome-directed
forces is provided by the plus-end-directed kinesin Eg5
along antiparallel MTs [4]. Eg5 activity is specifically
inhibited by MON [5]. To assess whether Eg5 affects
spindle pole fragmentation caused by Aurora-A inactiva-
tion, we used MON to inhibit Eg5 in combination with
the MLN8237 Aurora-A inhibitor. We pre-synchronised
U2OS cultures by thymidine arrest and release, then
treated released cultures during progression from S- to
M-phase with MLN8237, with or without MON, and
analysed mitotic spindle organisation (Figure 3). In these
experiments, MLN8237 treatment lasted 4 hours and
yielded the induction of spindle abnormalities (Figure 3,
upper histograms): these included multipolar spindles,
spindles with disorganised MTs often focussed in multi-
ple foci, some monopolar spindles and occasionally PMs
with few and short MTs. Spindles with multiple poles
represented 15-20% of all PM/Ms in MLN8237-treated
cultures (Figure 3, IF panels and lower histograms),
comparable to the occurrence in Aurora-Ai cultures.
When MON was added, Eg5 was inhibited (as revealed
by the presence of monopolar spindles in over 80% of
control mitoses), and the generation of spindles with
fragmented poles in MLN8237-treated cultures was
abolished (Figure 3), with a parallel increase in monopo-
lar figures (see example in the lower IF panels).
To further strengthen these results, we also performed
MON treatment in cultures continuously subjected to
Aurora-A RNAi. Simultaneous staining of MTs and
pericentrin showed that MON treatment of Aurora-Ai
cells inhibited PCM fragmentation and formation of
spindle extrapoles compared with Aurora-Ai cells with
active Eg5 (Figure 4). To further pinpoint the impor-
tance of Eg5-mediated forces in the generation of frag-
mented poles, we took advantage of the reversibility of
MON to restore Eg5 activity in Aurora-Ai mitoses after
MON wash-out (Figure 4). Eg5 activity was rapidly
resumed on addition of MON-free medium, as moni-
tored by the recovered ability of centrosomes to move
apart. Concomitant with Eg5 reactivation, spindle pole
fragmentation rapidly returned to comparable levels to
those seen in Aurora-Ai cultures. Thus, restoring Eg5
activity was sufficient to generate the fragmentation
phenotype induced by drug- or RNAi-mediated inactiva-
tion of Aurora-A.
The results thus far are consistent with the idea that
directional spindle forces are imbalanced in Aurora-Ai
mitoses, leading to pole fragmentation, and that proper
balance is restored by reducing centrosome-directed
MT forces. MT forces are therefore major players in the
spindle pole fragmentation event caused by Aurora-A
inactivation.
Interfering with KT-MT attachments prevents spindle pole
fragmentation induced by Aurora-A inactivation
In the experiments with MON, it was still possible that
spindle formation in Eg5-inhibited PMs was blocked at
a stage that preceded the Aurora-Ai-dependent frag-
mentation event. To distinguish between a specific tem-
poral implication of Eg5 and a global alteration of
spindle force orchestration in Aurora-A-defective cells,
an alternative approach was needed to unbalance MT
forces within the spindle.
During normal spindle assembly, K-fibers-generated
forces facilitate centrosome separation at PM [34] and
need counteracting by motor-associated MT-focusing
activities at poles [35]. We reasoned that reducing
KT-generated polewards forces can provide an alter-
native approach to unbalance spindle forces while
leaving motors undisturbed. To achieve this, we set
up RNAi protocols to inactivate the KT protein Nuf2
and thus destabilise KT-MT attachments [36] in
U2OS cells, in combination with Aurora-A inactiva-
tion by either MLN8237 treatment in synchronous
(Figure 5, IF panels and upper histograms) or RNAi-
mediated silencing in asynchronous cultures (Figure
6A). Using both experimental conditions, the occur-
rence of PM/M displaying spindle extrapoles was sig-
nificantly reduced in Nuf2/Aurora-A co-inactivated
cultures compared to those defective for Aurora-A
alone (Figure 5, lower histograms; Figure 6B). This
indicates that K-fibers are involved in the generation
of the pole fragmentation phenotype. Nuf2i typically
yields the appearance of elongated mitotic spindles
[35,36]. These elongated figures were unaffected by
the simultaneous inactivation of Aurora-A (Figure
6C): thus, Aurora-A/Nuf2 co-inactivation does not
necessarily restore the overall spindle shape or organi-
sation, but specifically prevents spindle pole fragmen-
tation. These results support the conclusion that, in
the absence of Aurora-A, KT-generated MT forces are
imbalanced at the level of the poles, causing excessive
pressure on poles and the ensuing fragmentation of
the PCM.
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Discussion
Among determinants of the spindle bipolar architecture,
forces generated by motor proteins moving along anti-
parallel or astral MTs [1,4], as well as by K-fibers
[34,35], have prominent roles. This work shows that
Aurora-A acts upstream of these forces. Several lines of
evidence demonstrate that in Aurora-A-defective cells
(either RNAi-silenced or MLN8237-inhibited) an imbal-
ance among MT forces within the spindle underlies the
fragmentation of spindle poles. First, Aurora-A-defective
mitoses display hyperstable MTs associated with spindle
pole fragmentation, but co-inactivation of ch-TOG
rescues the spindle pole fragmentation phenotype ([23]
and this work) and concomitantly counteracts the
abnormal MT hyperstabilisation caused by Aurora-Ai.
Second, MON specifically inhibits the kinesin Eg5 and
similarly attenuates the spindle pole fragmentation phe-
notype induced by either RNAi- or drug-mediated inac-
tivation of Aurora-A. ch-TOG and Eg5 regulate
independent functions during spindle assembly, respec-
tively as a MT stabiliser and a MT plus-end-directed
motor with crosslinking activity. The evidence that the
loss of either activity prevents Aurora-A-dependent pole
abnormalities, despite of their otherwise divergent
Figure 3 Eg5 inhibition counteracts the induction of spindle pole fragmentation by Aurora-A inactivation. The protocol to inhibit
Aurora-A by MLN8237 in cells progressing towards mitosis is depicted (time intervals not represented to scale). Control cultures were treated
with solvent (DMSO) in the same time window. When indicated, MON was added 1 hour before harvesting. Note the absence of active
phosphorylated (pThr288) Aurora-A (in red in IF panels) in cells treated with MLN8237. Upper histograms represent the percentage of all spindle
and MT abnormalities in control and MLN8237-treated cultures (200 counted PM/M per condition in 2 experiments); the grey fraction of the
histograms represents mitoses with spindle extrapoles, while other defects (monopolar or disorganised spindles, few and short MTs) are in white.
Lower histograms and IF panels show that concomitant Eg5 inhibition by MON prevents MLN8237-induced spindle pole fragmentation (note
the failure of centrosome migration reflecting Eg5 inactivation in lower IF panels). 200 PM/M per condition were counted in 2 experiments. Error
bars represent s.d. **: p < 0.001, c2 test. Red asterisks indicate significant differences with respect to DMSO controls, and black asterisks
significant differences between Aurora-Ai mitoses with active or inactive Eg5. Scale bar: 10 μm.
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biological functions, strengthens the idea that the rescu-
ing activity is associated with their shared property to
modulate pole-directed forces. Third, a similar inhibition
was also observed after silencing of the KT protein
Nuf2, under which condition MT-KT attachments are
destabilised. The common feature of the “rescuing” con-
ditions identified in this work is that they all decrease
MT-mediated pressure on poles. These data integrate in
the model illustrated in Figure 7, which schematises
how Aurora-A interplays with forces regulating spindle
pole formation: it is conceivable that in Aurora-A-defec-
tive cells the pressure directed towards poles is abnor-
mally high, or is not properly counteracted at the PCM
level, such that spindle poles fragment. Retrospectively,
this model is consistent with our previous observation
that the distance between the two main poles in Aur-
ora-Ai PMs displaying extrapoles is higher than in bipo-
lar spindles [23], a feature indicative of excessive
outwards-directed spindle forces. Together these results
indicate that Aurora-A is needed for establishing a
finely-tuned balance among MT-associated forces oper-
ating in bipolar spindle formation.
Here we have selected ch-TOG, Eg5 and Nuf2 as
paradigmatic examples of spindle regulatory activities
and have manipulated their relative abundance or activ-
ity as experimental tools to perturb the equilibrium
between MT forces. ch-TOG and Aurora-A are part of
a complex in human cells [37] and in Xenopus extracts
[38]. The Xenopus complex also contains Eg5 [38], and
Xenopus Eg5 is a substrate of Aurora-A [39]. A likely
possibility therefore is that Aurora-A regulates Eg5, and
possibly ch-TOG, by modulating their interactions, and,
in the case of Eg5, its phosphorylation status. Interest-
ingly, ch-TOG has recently been identified in a pro-
teome-wide search for potential Aurora-A substrates
based on a computational integrated approach [40],
although its actual phosphorylation by Aurora-A is not
demonstrated. As an independent approach to restore
the balance of forces within Aurora-Ai spindles, we have
silenced Nuf2 and found that this also rescues the loss
of spindle pole integrity in Aurora-A-defective mitoses.
This finding does not necessarily imply a direct link
between Aurora-A and the kinetochore protein Nuf2,
but is more likely to reflect a global re-balancing of MT
forces in Aurora-A-defective cells following the destabi-
lisation of MT-KT attachments, adding support to the
notion that K-fibers directly contribute to spindle pole
organisation [34,35].
Finally, the present data raise a concern that Aurora-A
inhibitors, currently under evaluation in anti-cancer
therapy, may facilitate the formation of multipolar spin-
dles and hence chromosome segregation defects. This
Figure 4 Spindle pole fragmentation in Aurora-Ai mitoses
depends on Eg5 activity. A schematisation of the protocol is
shown (time intervals not represented to scale). IF panels show
spindles displaying normal or fragmented poles in control and
Aurora-Ai cells, respectively (first and second row); monopolar
spindles in Aurora-Ai cells treated with MON (third row); spindles
displaying pole fragmentation in Aurora-Ai cells after MON release
(MON-rel; lower row). Histograms represent the percentage of PM/M
displaying fragmented poles, as assessed by alpha-tubulin (left) and
pericentrin (right) staining (200 to 400 counted cells per condition
in 2-4 experiments; s.d are shown). *: p < 0.01, **: p < 0.001, c2 test.
Scale bar: 10 μm.
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issue deserves careful consideration because it may have
opposite outcomes depending on the extent of chromo-
some imbalance and on the genetic background of can-
cer cells, e.g. for the status of tumor suppressors/
apoptosis-inducing genes. On the one hand, mild aneu-
ploidy facilitates tumorigenesis; on the other hand, mas-
sive aneuploidy generated by strong mis-segregation
defects yields inviable cellular progeny and it is therefore
regarded as a potential strategy to kill cancer cells ([41];
discussed in [42]). Investigating the long-term outcome
of Aurora-A-inactivated mitoses with “extrapoles” will
reveal whether they generate severely aneuploid inviable
daughter cells, contributing to the therapeutic potential
of Aurora-A inhibition, or on the contrary aneuploid
viable cells, which would instead represent a detrimental
consequence. Of relevance to this issue, we identify in
this study two conditions that mitigate the multipolar
phenotype induced by Aurora-A inhibition, i.e. inhibit-
ing Eg5 activity or KT-MT attachments. Interestingly,
inhibitors of either Eg5 or KT-MT interactions are also
proposed as useful molecules in anti-cancer therapies
[43,44]. An in-depth investigation of the interactions
between these classes of molecules will be useful to
devise effective therapeutic protocols.
Conclusions
The present work uncovers a novel function of Aurora-
A in orchestrating the balance between MT forces that
ensure the proper organisation of spindle poles. This
adds a novel aspect to the array of mitotic processes
downstream of this multifaceted kinase. Aurora-A is fre-
quently overexpressed in cancer and it is regarded as a
Figure 5 Nuf2 silencing prevents MLN8237-induced spindle pole fragmentation. A schematisation of the protocol for concomitant Nuf2
RNAi and Aurora-A inactivation (MLN8237) in cultures synchronously progressing from S-phase to mitosis is shown (time intervals not
represented to scale). The efficiency of Nuf2 depletion following the RNAi protocol is quantified in the upper histograms (Nuf2 staining; 100-200
counted cells per condition in 2 experiments; see representative images in IF panels). Lower histograms (PM/M cells with fragmented poles by
alpha-tubulin staining; 150-250 counted cells per condition, 2 experiments) and IF panels show that generation of extrapoles is reduced by Nuf2/
Aurora-A co-inactivation compared to Aurora-A inactivation alone. **: p < 0.001, c2 test. Red asterisks indicate significant differences with respect
to DMSO controls, and black asterisks significant differences between MLN8237-treated mitoses with (GL2i) or without (Nuf2i) the Nuf2 protein. s.
d are shown. Scale bar: 10 μm.
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Figure 6 Spindle pole fragmentation in Aurora-Ai mitoses depends on active Nuf2. A. The efficiency of Aurora-A and Nuf2 depletion after
RNAi was assessed by WB (left panels) and IF (right panels) analyses. B. Histograms represent the percentage of PM/M displaying fragmented
spindle poles (alpha-tubulin staining) after transfection with the indicated siRNAs (at least 200 cells per condition, 2 experiments). C. Elongated
spindles induced by Nuf2 RNAi are not rescued in Aur-Ai/Nuf2i co-inactivated cells (about 200 counted PM/M per condition in 2 experiments).
Spindle axes are schematised on the right: the pole-to-pole axis is longer in Nuf2i cells compared to controls. Error bars denote s.d. *: p < 0.01,
**: p < 0.001, c2 test. Scale bar: 10μm.
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promising target in anti-cancer therapies: our results
draw attention on possible “off-target” effects of thera-
peutic approaches entailing the inactivation of the
kinase. They also suggest that investigating the status of
spindle forces in Aurora-A-overexpressing cells may be
of relevance for our understanding of the mechanisms
that underlie Aurora-A transforming ability.
List of abbreviations
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pericentriolar material; PM: prometaphase; RNAi: RNA interference; siRNA:
small interfering RNA; WB: western immunoblotting.
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